Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases.
It is generally accepted that a limited number of T cell epitopes are generated by APC from an immunogenic protein. To ascertain the number of determinants on OVA recognized in the context of the H-2s haplotype, we generated 19 T-T hybridomas against OVA and H-2s and we synthesized 46 overlapping peptides spanning the entire protein. Eighteen T-T hybrids were stimulated by eight different peptides. The peptide recognized by one T cell hybrid was not identified. The effect of four protease inhibitors on the processing and presentation of OVA by the LS.102.9 B cell hybridoma seemed to implicate several groups of proteases in the processing of this Ag. Alkylation of cysteine residues with iodoacetic acid showed in a few cases a dramatic decrease in the capacity of OVA to stimulate T-T hybrids recognizing cysteine-free peptides. In contrast, two T-T hybrids recognizing cysteine containing peptides were not affected by the alkylation, suggesting that alkylation inhibited the processing of OVA without affecting peptide interaction with class II MHC molecules. These data demonstrate that the repertoire of peptides generated by APC from OVA is not limited to one or few immunodominant peptides, and results from the activity of several endopeptidases and/or exopeptidases. In addition, the structure of the Ag (native or denatured) was shown to affect the efficiency with which different epitopes are generated.
Vidard
L
L
Dana-Farber Cancer Institute, Division of Lymphocyte Biology, Boston, MA 02115.
Rock
K L
KL
Benacerraf
B
B
D000818:Animals; D000938:Antigen-Presenting Cells / Q000502:physiology; D010450:Endopeptidases / Q000502:physiology*; D000939:Epitopes / Q000032:analysis*; D006183:H-2 Antigens / Q000235:genetics*; D051379:Mice; D010047:Ovalbumin / Q000276:immunology*; D011480:Protease Inhibitors / Q000494:pharmacology; D011487:Protein Conformation; D013601:T-Lymphocytes / Q000276:immunology*
D000939:Epitopes; D006183:H-2 Antigens; D011480:Protease Inhibitors; D010047:Ovalbumin; D010450:Endopeptidases